Navigation Links
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
Date:12/16/2013

,  which have been filed with the SEC and in the case of Valeant, the CSA. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, could cause the companies' actual results to differ materially from expected and historical results. The companies assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

Additional Information and Where to Find It
The tender offer described in this release has not yet commenced and this release is not a recommendation or an offer to purchase or a solicitation of an offer to sell shares of Solta. At the time the tender offer is commenced Sapphire Subsidiary Corp. and Valeant will file a Tender Offer Statement on Schedule TO, containing an offer to purchase, form of letter of transmittal and related tender offer documents, with the SEC and Solta will file a Solicitation/Recommendation Statement on Schedule 14D-9 relating to the tender offer with the SEC. Valeant and Solta intend to mail these documents to the stockholders of Solta. These documents, as they may be amended from time to time, will contain important information about the tender offer and stockholders of Solta are urged to read them carefully when they become available. Stockholders of Solta will be able to obtain a free copy of these documents, when they become available, at the website maintained by the SEC at www.sec.gov. In addition, the Tender Offer Statement and other documents that Valeant files with the SEC will be made available to all stockholders of Solta free of charge at www.valeant.com. The Solicitation/Recommendation Statement and the other documents filed by Solta with the SEC will be made available to all stockholders of Solta free of charge at www.Solta.com.'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
2. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Valeant Pharmaceuticals To Host Investor Day
4. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
5. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
7. Valeant Pharmaceuticals Announces Management Change
8. Valeant Pharmaceuticals To Syndicate Incremental Loans
9. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
10. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015  On May ... will convene in Santa Monica, CA ... on Lung-Sparing Therapies for Malignant Pleural Mesothelioma (MPM), ... exposure to asbestos and commonly affects the lining ... co-hosted by UCLA and the Pacific Mesothelioma Center ...
(Date:3/31/2015)... March 31, 2015 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" ... premium quality medical marijuana products and a licensed producer ... Purposes Regulations ( Canada ) ("MMPR"), is ... The Corporation of the District of Saanich ... Company,s premises which now allows for commercial distribution of ...
(Date:3/31/2015)... ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ... 225mg and 300mg oral tablets, indicated for use in ... for Propafenone Hydrochloride 150mg, 225mg and 300mg tablets was ... Arthur S. Przybyl , President and Chief Executive ... of our fourth product from the portfolio of approved ...
Breaking Medicine Technology:Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 2Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 3Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 4T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 3ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3
... Calif., Oct. 28 Although Breast Cancer Awareness Month is coming ... health is important throughout the year. What,s more, women age ... their potential risk for breast cancer. Based on the same ... the only FDA-cleared risk assessment tool for non-hereditary breast cancer. ...
... HOERSHOLM, Denmark and SAN DIEGO, California, October ... Mark Wedel, MD, FACP Joins as Vice President and Chief,Medical ... , - Stuart Mackey, JD joins ... Business Development for Proprietary RNA-targeted,Locked Nucleic Acid (LNA) Drug Platform ...
Cached Medicine Technology:Breast Health is a Year-Round Priority: New Technology Identifies Risk of Breast Cancer in Younger Women 2Breast Health is a Year-Round Priority: New Technology Identifies Risk of Breast Cancer in Younger Women 3Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs 2Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs 3Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs 4
(Date:3/31/2015)... 31, 2015 Indosoft, Inc., developers of ... the availability of SIP over TCP configuration for all SIP ... offering a full contact center ACD (Automatic Call ... Adding SIP over TCP support to all SIP devices gives ... The history of Voice over IP (VoIP) has primarily involved ...
(Date:3/31/2015)... Exton, PA (PRWEB) March 31, 2015 ... to the physical, social and psychological benefits of ... about the thousands of adaptive sports athletes that ... United States, encourage support for inclusive fitness and ... individuals interested in participating in adaptive sports and ...
(Date:3/31/2015)... 31, 2015 Array Health , ... has announced that Lance Hood, Senior Director of Marketing, ... Exchange Forum on April 1, 2015. The session, co-presented ... will address how employers can streamline and simplify the ... WHAT: “ Optimizing Employee and Employer Needs in a ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 With intravenous ... vein using a catheter. Patients, typically, are prescribed IV ... that oral medications are no longer effective. Illness ... needed to help with electrolyte imbalances. Infusion therapy ... illness. In addition to treating dehydration, IV infusion therapy ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 The ... Health Care Administrators (ACHCA) elected two administrators from ... and long-term care in New Jersey, to two ... of new officers. Robert Reyes, administrator for Abingdon ... elected president, and Yael Herman, administrator of Canterbury ...
Breaking Medicine News(10 mins):Health News:Indosoft extends SIP over TCP support to User Extensions in its Q-Suite 5.9 Call Center Software 2Health News:April is National Adaptive Sports Month 2Health News:April is National Adaptive Sports Month 3Health News:Array Health’s Senior Director of Marketing to Co-Present with Benaissance at The Institute for HealthCare Consumerism Private Exchange Forum 2Health News:Intravenous Infusion Therapy Now Available at Urgent Care of Texas Centers; Hospital-Level Care in an Outpatient Setting. 2Health News:Abingdon Care & Rehabilitation Center’s Administrator Elected President of N.J. Chapter of the American College of Health Care Administrators 2
... study by Ceylan, from Turkey evaluated their experience in ... ,Their patient's ages ranged from 5 months to 24 ... circumcisions were performed at various centers or during religious ... ,The group found that the most commonly observed complication ...
... chemicals and industrial effluents in sea and soil could increase your ... was thought to be the most important factor in the development ... does not produce enough insulin - necessary for the body to ... South Korean researchers has shown that people whose bodies are polluted ...
... a lifetime.” , - Herbert Ward //, Child Abuse-The Bitter ... her imaginative world of fairies and angels, while her mom eked ... door jolted her out of her joyous reverie. She hastened to ... in disguise. He locked the door and raped her repeatedly. ...
... and Levitra are the answer to their prayers. But, ... report from Harvard Medical School, these pills offer no ... frequently accompany erectile dysfunction (ED). ,For one ... feeling sexual desire for his partner. If emotional issues ...
... already pressured hospital system would struggle to cope under ... a large-scale emergency, say trauma and emergency specialists.// ... targets for Australasian hospitals, says Dr Anthony Joseph, Director ... ,In the latest Medical Journal of Australia ...
... recently has shown that students who participate in sexual ... those who did not participate in the program. The ... desired positive impact. ,Critics have always ... the Federal government annually on the ‘abstinence-until-marriage education’may not ...
Cached Medicine News:Health News:Child Abuse - When God’s Gifts Land in Devils’ Clutch 2Health News:Child Abuse - When God’s Gifts Land in Devils’ Clutch 3Health News:Can Our Hospitals Cope In A Disaster? 2
... Oncor brings together Siemens existing patented ... MLC, and Virtual Wedge, with the ... workflow, patient position offset determination, and ... provide maximum efficiency of treatment delivery ...
The Primus linear accelerator is a fully digital, technologically advanced radiation therapy treatment delivery system. It can be configured for delivery of routine, 3-D conformal or IMRT treatments....
... EX accelerators are true ... Varian multileaf collimation and ... which enable you to ... computer-driven IMRT treatments, as ...
... Clinac EX accelerators are ... integrated Varian multileaf collimation ... systems which enable you ... advanced computer-driven IMRT treatments, ...
Medicine Products: